MoCAalso known as Montreal Cognitive Assessment or The MoCA Testwas validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI) in 2000. not having used prior to MoCA assessment classified as <7 days, 741 days or 42 days), abstinence duration (i.e. For the Earliest and Most Accurate Detection of Mild Cognitive Impairment. Our results suggest that the MoCA test is a useful screening instrument for assessing cognitive impairment in psychotic patients and has some advantages over other available instruments, such as its ease-of-use and short administration time.Ĭognitive impairment Cognitive screening MoCA Schizophrenia. The second aim is to investigate the effects of age, abstinence (i.e. Receiver operating characteristic (ROC) analysis suggested a <25 cut-off for cognitive impairment instead of the original <26. The Montreal Cognitive Assessment (MoCA), a brief cognitive assessment tool, has been used widely in different clinical settings because of its high sensitivity and specificity for detecting cognitive impairments. We also found significant associations between 5 out of 7 MoCA subtests (visuospatial-executive, attention, language, abstraction and delayed recall) and MCCB subtests but not for the naming and orientation MoCA subtests. Concurrent validation was found between the total scores of the MoCA and MCCB. The Montreal Cognitive Assessment (MoCA) has been used in individuals with schizophrenia as another screening instrument with variable results. Two cut-off scores for cognitive impairment using the MCCB were applied (T score <40 and < 30). Patients were psychopathologically assessed, and the MoCA test and MATRICS Consensus Cognitive Battery (MCCB) were administered. One hundred-forty stabilized patients were re-evaluated more than 15 years after a First Episode of Psychosis (FEP). This study explores the usefulness of this instrument to detect cognitive impairment in long-term psychotic disorders. The Montreal Cognitive Assessment (MoCA) has been used in individuals with schizophrenia as another screening instrument with variable results. ![]() ![]() The Montreal Cognitive Assessment (MoCA) is a brief tool that has been shown to be effective in identifying mild cognitive impairment and early dementia. In the current work, a shortened version of the MoCA (miniMoCA) was. ![]() The MoCA assesses a broader range of domains affected in PD, including attention, executive functions, and visuoperception. Cognitive impairment is a key feature in patients with psychotic disorders. Implications for rehabilitation: Although the Montreal Cognitive Assessment (MoCA) is a recommended tool to screen for cognitive impairment in stroke patients, its lengthy administration can lead to inconsistent screening of patients for post-stroke cognitive function. Recently, the Montreal Cognitive Assessment (MoCA) has been proposed as a screening instrument that is sensitive to mild cognitive impairment and the early cognitive changes of Parkinson’s disease.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |